Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries .. Read more
Serum Institute of India Pvt. Ltd. (SIIPL) becomes the First Company to Submit a Prequalification Dossier (PQD) to WHO in eCTD Format on the New ePQS Portal .. Read more
SCHOTT Pharma & SII welcomes new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla .. Read more
